FN2 Earnings Intelligence
Biogen Inc. balance sheet (quarterly)
Biogen Inc. (BIIB) Balance Sheet (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/31/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $2,598.3 | $2,758.8 | $3,862.8 | $3,382.7 | $1,285 | - | - |
| + Debt | $6,297.8 | $6,283.7 | $6,285.1 | - | $8,090.3 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2,431 | $2,645.5 | $2,534.7 | $2,477.8 | $2,736 | $2,566.2 | $2,543.6 |
| % Growth | - | - | - | - | - | 1.2% | - |
| Gross Profit | $1,801.7 | $2,040.5 | $1,860.3 | $1,816.8 | $1,959.1 | - | - |
| % Margin | 74.1% | 77.1% | 73.4% | 73.3% | 71.6% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $240.5 | $634.8 | $466.5 | $319.5 | $97.5 | - | - |
| % Margin | 9.9% | 24.0% | 18.4% | 12.9% | 3.6% | - | - |
| Diluted EPS | $1.64 | $4.33 | $3.17 | $2.15 | $0.66 | $2.39 | $3.54 |
| % Growth | - | - | - | - | - | -24.5% | - |
| Operating Cash Flow | $259.3 | - | - | $645.5 | - | - | - |
| CapEx | $37.1 | - | - | $51.2 | - | - | - |
| Free Cash Flow | $222.2 | - | - | $594.3 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/31/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2,431 | $2,645.5 | $2,534.7 | $2,477.8 | $2,736 | $2,566.2 | $2,543.6 |
| Gross Profit | $1,801.7 | $2,040.5 | $1,860.3 | $1,816.8 | $1,959.1 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $240.5 | $634.8 | $466.5 | $319.5 | $97.5 | - | - |
| Diluted EPS | $1.64 | $4.33 | $3.17 | $2.15 | $0.66 | $2.39 | $3.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,598.3 | $2,758.8 | $3,862.8 | $3,382.7 | $1,285 |
| Short-term Debt | $1,749.1 | $0 | $0 | - | $800 |
| Long-term Debt | $4,548.7 | $6,283.7 | $6,285.1 | $6,288.5 | $7,290.3 |
| Total Debt | $6,297.8 | $6,283.7 | $6,285.1 | - | $8,090.3 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $259.3 | - | - | $645.5 | - |
| Capital Expenditure | $37.1 | - | - | $51.2 | - |
| Free Cash Flow | $222.2 | - | - | $594.3 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 74.1% | 77.1% | 73.4% | 73.3% | 71.6% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 9.9% | 24.0% | 18.4% | 12.9% | 3.6% |
| FCF Margin | 9.1% | - | - | 24.0% | - |
| Diluted EPS Growth | - | - | - | - | - |